(Q41125993)

27 September 2017

1 reference

title

Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer (English)

1 reference

27 September 2017

1 reference

J Schlom

1

1 reference

27 September 2017

J Kantor

2

1 reference

27 September 2017

S Abrams

3

1 reference

27 September 2017

K Y Tsang

4

1 reference

27 September 2017

D Panicali

5

1 reference

27 September 2017

J M Hamilton

6

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

Breast Cancer Research and Treatment

27 September 2017

1 reference

27 September 2017

38

1 reference

27 September 2017

1

1 reference

27 September 2017

27-39

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01803781

27 September 2017

0 references

cites work

Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies

1 reference

12 December 2020

Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients

1 reference

12 December 2020

In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein.

1 reference

12 December 2020

Vaccinia recombinants expressing secreted and transmembrane forms of breast cancer-associated epithelial tumour antigen (ETA)

1 reference

12 December 2020

Anti-Idiotype Monoclonal Antibodies as Vaccines for Human Cancer

1 reference

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

12 December 2020

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

1 reference

12 December 2020

A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)

1 reference

12 December 2020

Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene

1 reference

12 December 2020

Is carcinoembryonic antigen an autoantigen?

1 reference

12 December 2020

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

1 reference

12 December 2020

CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes

1 reference

12 December 2020

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

12 December 2020

Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.

1 reference

12 December 2020

B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells

1 reference

12 December 2020

Baculovirus recombinants expressing the human carcinoembryonic antigen gene.

1 reference

12 December 2020

Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

1 reference

12 December 2020

Circulating immune complexes in patients with colorectal cancer

1 reference

12 December 2020

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1 reference

12 December 2020

The antigenicity of carcinoembryonic antigen in man.

1 reference

12 December 2020

Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate

1 reference

12 December 2020

Human B-cell immune response to the polymorphic epithelial mucin.

1 reference

12 December 2020

Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant

1 reference

12 December 2020

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

1 reference

12 December 2020

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector

1 reference

12 December 2020

Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas

1 reference

12 December 2020

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

1 reference

12 December 2020

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

12 December 2020

Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.

1 reference

12 December 2020

A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01803781

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference